DSG Press Releases

DSG Press Releases – For the eClinical and life sciences industries

PhaseBio Pharmaceuticals eCaseLink

DSG Supports PhaseBio Pharmaceuticals with Unified Clinical Trial Software Platform for COVID-19 Trial.

MALVERN, Pa., July 17, 2020 – DSG, Inc., a global leader of eClinical software solutions and services for the life sciences industry has successfully launched a COVID-19 study with PhaseBio Pharmaceuticals for its potentially pivotal clinical trial evaluating PB1046 as a treatment for hospitalized COVID-19 patients who are at high risk for rapid clinical deterioration and acute respiratory distress syndrome (ARDS).

eCaseLink 10 at DIA 2018

ENHANCING THE EDC EXPERIENCE WITH ECASELINK 10 FROM DSG

BOSTON, June 25, 2018 – DSG, Inc., an industry leader in eClinical software and services to the life science industry, today announced that it will be releasing the newest version of their flagship eCaseLink™ EDC at the heart of their unified eClinical suite of products: eCaseLink10. This latest offering from DSG will be highlighted at the 54th DIA Global Annual Meeting and Conference, June 24-28 in Boston, MA at the Boston Convention Center.

The Boston Convention Center

DSG TO ATTEND 54th DIA GLOBAL ANNUAL MEETING IN BOSTON

MALVERN, Pa., June 4, 2018, – DSG, Inc., an industry leader in eClinical software and services to the life science industry will be exhibiting at the 54th DIA Global Annual Meeting and Conference at island 1707. The conference is set to take place June 24-28, 2018 in Boston, Massachusetts at the Boston Convention and Exhibition Center. The DIA Global Annual Meeting musters together innovation leading life science professionals from across the spectrum of the medical world to help better collaborate on solving the medical issues of the future.

17th MIXiii-BIOMED 2018 Conference and Exhibition

DSG TO ATTEND 17th MIXiii-BIOMED IN TEL AVIV, ISRAEL

MALVERN, Pa., May 2, 2018, DSG, Inc., an industry leader in eClinical software and services to the life sciences industry will be exhibiting at the 17th MIXiii-BIOMED 2018 Conference and Exhibition. The MIXiii-BIOMED conference will further the knowledge of clinical research, healthcare systems and life sciences through the power of innovative technological trends. DSG is attending for the first time and will be showcasing the latest innovations in Clinical data collection and management to the fast-growing and vibrant Israeli life sciences community.

DSG TO ATTEND ASIAN PHARMA IT SUMMIT IN SHANGHAI, CHINA

MALVERN, Pa., April. 25, 2018, DSG, Inc., a leader in eClinical software and services to the life science industry will be exhibiting at the Asian Pharma IT Summit 2018. The conference is set to take place June 12th to June 13th in Shanghai, China at the Crowne Plaza Century Park. The Asian Pharma IT Summit stands as one of the most respected and anticipated conferences throughout the pharmaceutical technological world. DSG is attending for the first time as it seeks to increase its presence in the emerging Asian region.

DSG TO ATTEND PHAR-EAST CONFERENCE IN SUNTEC, SINGAPORE

MALVERN, Pa., Feb. 19, 2018, DSG, Inc., a leader in eClinical software and services will be exhibiting at the Phar-East - Asia’s Pharma & Biotech Conference. The conference is set to take place February 28th to March 2nd at the Suntec Signore Convention & Exhibition Centre, in Suntec City Singapore. “This is our first year attending the Phar-East conference; I look forward to educating attendee’s on our robust software and give a better understanding of what separates us from our competitors,” said Al Campbell, vice president, strategic alliances and director, business development.

DSG ATTENDING OUTSOURCING IN CLINICAL TRIALS CONFERENCE IN BURLINGAME, CALIF.

MALVERN, Pa., Feb.12, 2018, DSG, Inc., a leader in eClinical software and services will be attending the Outsourcing in Clinical Trials, West Coast (OCT) Conference in Burlingame, CA. The conference will be held from February 21-22, 2018 at the Hyatt Regency San Francisco Airport. For 10 years, Arena International’s flagship Outsourcing in Clinical Trials West Coast conference has drawn more than 700 clinical professionals from the Bay Area and beyond, to discuss clinical outsourcing strategies and overcome key challenges within clinical operations.

FDA APPROVES NANOCOATED CORONARY STENT SYSTEM USING DSG’s eClinical System Software.

MALVERN, Pa., March 23, 2017, CeloNova Biosciences, Inc. leveraging products and services provided by DSG Inc., a leading eClinical software technology and data management global services firm, has recently received US Food and Drug Administration (FDA) approval of its first-in-class COBRA PzF ™ NanoCoated Coronary Stent System.

DSG’s eCaseLink EDC allowed CeloNova Biosciences to manage subject enrollment and capture data efficiently in the global clinical trial of the COBRA PzF Coronary Stent. DSG handled all aspects of clinical study data management from database setup through lock.DSG's data management team added value to their eCaseLink EDC solution by providing CeloNova Biosciences with clean, timely, and cost-effective deliverables and week-to-week metrics showing their own progress throughout the lifespan of the study,” said Mark Barakat, MD, Senior Director, Medical Affairs at CeloNova.

DSG, INC. ACCELERATES GROWTH WITH OPENING OF NEW OFFICE IN BANGALORE, INDIA

MALVERN, Pa., Bangalore, India, January 2017 — DSG, Inc., leading provider of eClinical technology solutions, data management, professional services and customer support recently opened a new office in Bangalore, India, to accommodate rapid growth and better serve client needs. DSG's Bangalore office will complement its existing facility located in Noida, India. DSG Bangalore’s state-of-the-art facility will occupy a floor in the Prestige Shantiniketan building. The new office space will accommodate over 300 people and support the company’s growth strategy.

Read more »
Contact DSG
Quick links